We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Nanopore Array Designed to Provide Simultaneous Tests in Search for New Drugs

By LabMedica International staff writers
Posted on 06 Dec 2010
Scientists in Germany are utilizing an innovative, automatable lab-on-chip device for high-throughput screening of sensitive membrane proteins.

Membrane-associated receptors, channels, and transporters are among the most important drug targets for the pharmaceutical industry. More...
The hunt for new drugs is similar to looking for a needle in a haystack. Therefore, new analytic techniques are required that facilitate the simultaneous screening of a large library of compounds across a variety of membrane proteins.

However, this class of technology is still at the early stages of development. The group of researchers who devised the technique included Prof. Dr. Robert Tampé, from the Institute of Biochemistry, Biocenter Goethe Universität (Frankfurt, Germany), in collaboration with investigators from the Walter Schottky Institute at Technical University Munich (Germany).

The study was published online October 27, 2010, in the journal Nano Letters, where the scientists described the analysis of membrane proteins on a nanofabricated chip surface that contains nearly 50,000 nanopores. These pores are covered by a freely suspended lipid membrane that incorporates the proteins to be analyzed. Because the lipid membrane is free of organic solvents and the proteins do not touch the solid support, the fragile structure and therefore function of the proteins is maintained.

The system can be used to monitor the transport kinetics of membrane proteins by fluorescence microscopy, according to the scientists. Due to the parallel design of the nanopore chip, a large number of samples can be analyzed simultaneously.

Related Links:
Institute of Biochemistry, Biocenter Goethe Universidad
Walter Schottky Institute at Technical University Munich



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.